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We agree with Dr. Hiatt that epidemiology belongs at the
epicenter of translation (1), especially when integration of
knowledge across disciplines is required to create the scien-
tiﬁc basis for societal change. Although we recognize his
concern that the ‘‘proliferation of T’s’’ could get out of
hand, we believe that our more granular description of trans-
lation helps to highlight epidemiology’s role beyond the
identiﬁcation of risk factors (2).
Unfortunately, the thesis that epidemiology is at the epi-
center of translation science is not universally shared. Al-
though it is difﬁcult to think of any medical progress that
really saved lives and has not required a key contribution
from epidemiology, no Nobel Prize has ever been awarded
to an epidemiologist (3). In a recent 37-chapter authoritative
textbook entitled Clinical and Translational Science (4), we
had to wait until chapter 35 to read an introduction to epi-
demiology, which relegates the contributions of epidemiol-
ogy to an afterthought in the translational sciences. One
wonders whether the oft-lamented lack of successes in
translational research is due to the lack of wider understand-
ing of epidemiologic methods among researchers of diverse
disciplines.
As Hiatt afﬁrms, the point is that epidemiology has a
central role throughout the translation continuum, regard-
less of what the overlapping phases are called. Epidemiol-
ogists come in all kinds ofﬂavors. Some practice discovery
research almost exclusively; others focus on development
of evidence-based guidelines. Still more are engaged in
clinical and public health practice, developing and imple-
menting programs and measuring health impact at the
national, state, and local levels. Their work is to measure
factors that facilitate and impede the integration of proven
interventions into practice (T3) and to assess the effective-
ness of interventions in reducing morbidity and mortality
at the population level (T4). Because both process and
outcome measures are needed to evaluate interventions,
T3 and T4 obviously overlap. Often T3 data are available
years, if not decades, before T4 data, and the sources of
data and methods used may differ. For example, surveil-
lance systems are mainstays of public health programs
that evaluate both process indicators, such as trends in
the prevalence of cigarette smoking in the Behavioral Risk
Factor Surveillance System (5), and outcome indicators,
such as trends in lung cancer incidence using Surveillance,
Epidemiology, and End Results (SEER) or state-based
cancer registries (6). Many discoveries may look promis-
ing, managing to survive through T1 and T2 evaluations,
and becomewidely accepted in medicine and public health
only to be proven ineffective and harmful (7, 8). T3 assess-
ments alone (collecting process indicators) would simply
enhance wasted efforts, while T4 research can offer valu-
able hints that we have been misled and/or inform new
discoveries (T0).
Our reason for highlighting T3 and T4 is not to create
new niches or to divide disciplines but to spotlight epide-
miology as a common thread along the entire translation
continuum. Our quick review of the Journal publications
suggests much less emphasis on T3 and T4 compared with
discovery and early translation. Our bottom line is simple.
The road to translation is long and arduous. We need to
cross all the T’s even though we may disagree on what to
call them. Epidemiologists should play a much larger role in
this enterprise in academic, clinical, or public health prac-
tice settings.
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